Navigation Links
Caraco Pharmaceutical Laboratories Ltd. to Announce Second Quarter of Fiscal Year 2009 Results on October 23, 2008
Date:10/16/2008

DETROIT, Oct. 16 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (Amex: CPD) announced that the Company intends to release results for its second quarter of fiscal year 2009, ended September 30, 2008, on Thursday October 23, 2008.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward- looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission and include, but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or cheaper products or new technology for the production of products, the entry into the market of new competitors, market and customer acceptance and demand for new pharmaceutical products, availability of raw materials, timing and success of product development and launches, dependence on few products generating majority of sales, product liability claims for which the Company may be inadequately insured, and other risks identified in this report and from
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
2. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation from Board of Directors of Jitendra Doshi and Appointment of GP Singh Sachdeva
3. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 S*BIO Pte Ltd today announced d..., SB1518, at The American Society of Hematology 51..., Data will be presented on the clinical result... detailing its safety, tolerability and pharmacoki...ls ranging from 100 to 600 mg. These doses were ad...
(Date:12/2/2009)...PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NAS...iopharmaceutical company focused on endocrine ther...od and Drug Administration (FDA) has granted Fast ...ay inhibitor compound, perifosine (KRX-0401), for ...oma. Keryx Biopharmaceuticals, Inc. ("Keryx") ( KE...
(Date:12/2/2009)...2 According to the National Instit...ns diagnosed with diabetes already have some stage...amage to the retina caused by leaky blood vessels,...etes and is one of the most feared diabetic compli...s who,ve had diabetes for 10 years or more will ex...
(Date:12/1/2009)...1 Reportlinker.com announces that ...atalogue: ,, Chromium - Global Market Trends ...mium---Global-Market-Trends.html ,, Worldwide ...inless steel, while growth in aerospace and indust...wth of chromium metal. Environmental constraints a...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
... Joins Trial with James Pingpank, MD, FACS, as Pri...lcath Systems, Inc. (Nasdaq: DCTH ) announced t...sity of Pittsburgh Medical Center (UPMC), has joi... Percutaneous Hepatic Perfusion (PHP) System again...ames Pingpank, MD, FACS, Associate Professor Surge...
...rance, December 2 NicOx S.A.,(NYSE Euronext Paris...with,DSM for the commercial manufacture and supply...rmaceutical ingredient). Naproxcinod is NicOx, lea...n the,Cyclooxygenase-Inhibiting Nitric Oxide-Donat...ch recently achieved positive results in the,third...
...Newswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Alter...hina, announced today that, the,Health Services Bu...spended,the use of 83 doses of inactivated hepatit... death of a minor in the Fengtai District on Novem...on of the vaccine two days prior. , The susp...
Other Biology Technology:Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 2Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 3Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 4NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4Sinovac Releases Statement on Healive Vaccine Suspension 2
(Date:12/2/2009)...EDWOOD SHORES, Calif. and PALM HARBOR, Fla., Dec. ...ence Corporation ("CIC") (OTC Bulletin Board: CICI...tions for business process automation in the finan...etric signature verification and Docubase Systems ...nic Document Management (EDM) software provider an...
(Date:12/2/2009)...er 2, 2009 Commonly prescribed beta 2 adrenergic ...ant women as well as pre-term labor may increase t...tric pathology, cognitive problems and poor school... study published in the December 2009 issue of the... Beta 2 adrenergic agonist drugs as a class are w...
(Date:12/2/2009)...BOKEN, NJ According to the National Institute of ...nosed with diabetes already have some stage of dia...o the retina caused by leaky blood vessels, is a m...d is one of the most feared diabetic complications...e had diabetes for 10 years or more will experienc...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3ERT Achieves Cardiac Safety Milestone after Completing 150th TET Trial 56144 1ERT Achieves Cardiac Safety Milestone after Completing 150th TET Trial 56144 2ERT Achieves Cardiac Safety Milestone after Completing 150th TET Trial 56144 3My1Stop com Named 2009 Inc 500 5000 Honoree 56140 1My1Stop com Named 2009 Inc 500 5000 Honoree 56140 2FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines 56136 1FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines 56136 2FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines 56136 3
... horses. Hatching inside over-ripe fruit where the...vironment until nature sends them an offer they ca...wander off and burrow into the earth where they av...arvae grow and hatch into flies that will take win...hers from the University of Georgia has discovered...
...orcement agents, supports CFCE training by ...FIELD, Mich., May 9 The Center for Computer,Foren... Ed Moore, one of,its examiners, as a volunteer co...sics Computer Examiners (CFCE). Moore, a forensic ...ill lend his 8 years of forensics,expertise as a g...
...me sequence of the duck-billed platypus was publis...revealing clues about how genomes were organized d... was supported in part by the National Human Genom... Institutes of Health (NIH). , Fans of TV nature..., native to Australia, is one of the few mammals t...
Other Biology News:Fruit fly avoidance mechanism could lead to new ways to control pain in humans 2Center for Computer Forensics Offers Expert to Volunteer as CFCE Certification Applicants Coach 2Duck-billed platypus genome sequence published 2Duck-billed platypus genome sequence published 3Duck-billed platypus genome sequence published 4
Matrigel Matrix 100 mm Culture Dishes for Hepatocytes from BD Biosciences - Discovery Labware
...TE-d7 is used as an internal standard for the quan...mass spectrometry. 5-OxoETE is a polyunsaturated k...n neutrophils. It stimulates cytosolic calcium lev...selectively stimulates the migration and degranula...
...TE-d7 is used as an internal standard for the quan...mass spectrometry. 5-OxoETE is a polyunsaturated k...n neutrophils. It stimulates cytosolic calcium lev...selectively stimulates the migration and degranula...
Mouse Anti-HD Monoclonal Antibody, Unconjugated, Clone 3D6 from Abnova Corporation
Biology Products: